Motor and cognitive exercise program for Parkinson's disease
Official title: Motor and Cognitive Exercise in Parkinson's Disease. A Feasibility Randomized Clinical Trial
Run by University Hospital Bispebjerg and Frederiksberg · NCT07465107 · Data updated 2026-11-12
This project tests whether adding a 12-week supervised motor-and-cognitive exercise program to usual care improves walking and balance for people with Parkinson's disease who have had symptoms for at least 4 years.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 48 (estimated) |
| Sponsor | University Hospital Bispebjerg and Frederiksberg Academic / other |
| Locations | 1 site (Copenhagen NV) |
| Status | Recruiting |
| Started | March 26, 2025 |
| Main results expected | February 14, 2027 |
| Study ends | February 14, 2027 |
| Registry record updated | March 11, 2026 |
| Trial ID | NCT07465107 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) with Parkinson's disease by MDS criteria, symptom duration of at least 4 years, who can walk independently and can provide informed consent are ideal candidates.
✕Probably not a fit
People with Parkinson's disease dementia, those unable to walk independently, or with unstable medical issues are unlikely to benefit or may be ineligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In a randomized 1:1 feasibility trial, 48 people with Parkinson's disease and symptom duration of four or more years will be assigned to usual care or to a 12-week supervised exercise program plus usual care. The intervention includes treadmill gait and dual-task motor-cognitive training, progressive gait and balance exercises, and progressive lower-body resistance training delivered three times per week for one hour by a physiotherapist or exercise physiologist. Outcomes will be measured at baseline, 12 weeks, and at 6- and 12-month follow-up to capture short- and longer-term effects. The protocol was developed with the Copenhagen Trial Unit and detailed training protocols will be shared to support reproducibility.
Why it matters
Potential benefit: If successful, the program could improve gait and balance, help reduce fall risk, and preserve mobility for people with moderate-to-advanced Parkinson's disease.
How similar studies have gone: Previous exercise and dual-task training studies in Parkinson's disease have shown promising improvements in gait and balance, so this builds on encouraging but not definitive evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of PD according to MDS-PD criteria * Aged ≥ 18 years * Informed consent * PD symptoms ≥ 4 years * Independent gait Exclusion Criteria: * Diagnosis of PD Dementia according to the MDS-PD Dementia criteria
Where it's running
-
Department of Neurology, Bispebjerg and Frederiksberg Hospital
Copenhagen NV, Denmark Recruiting
Study contacts
- Study coordinator: Annemette Løkkegaard, MD, PhD
- Email: annemette.loekkegaard@regionh.dk
- Phone: +45 38 63 52 48
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Parkinson’s Risk in Gaucher Disease Type 1
This study tests how Parkinson’s risk relates to GBA1-related Gaucher disease in adults over 40, by collecting detailed clinical data and samples for future research.
-
Can the Ronnie Gardiner Method improve thinking and daily function in people with Parkinson’s
In this 10-week program, adults with Parkinson’s disease will try the Ronnie Gardiner Method to see if it helps thinking, talking, movement, balance, and quality of life.
-
Effects of excitatory and inhibitory LIFUS of GPi in Parkinson’s patients without DBS
This study tests two deep-brain focused ultrasound patterns on people with Parkinson’s to see if they change task performance and tremor, compared with a sham stimulation.
-
Capacitive-resistive radiofrequency therapy for people with Parkinson's disease
This study tests four TECAR therapy protocols on the legs to see which best reduces muscle stiffness and improves walking in people with Parkinson's disease.
-
TRB-001 safety and immune response in early Parkinson's disease
This early-phase study tests TRB-001 against placebo to see if it is safe and prompts an immune response in people with recently diagnosed Parkinson’s disease.
-
Bayesian optimization to tune DBS for better gait in Parkinson’s patients
This study tests whether using Bayesian optimization can quickly find DBS settings that lengthen step length in people with Parkinson's who already have DBS in place.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.